Cargando…

A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery

BACKGROUND: Transforaminal Lumbar Interbody Fusion (TLIF) is commonly associated with higher complications and longer operative time. This study aims to evaluate the effectiveness, safety, and usability of a novel minimally invasive surgery (MIS) bone graft delivery device. METHODS: 73 consecutive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kai-shun, Chen, Chih-Wei, Yau, Ru-Bin, Liang, Huang-Chien, Ko, Ching-Chung, Kuo, Jinn-Rung, Chio, Chung-Ching, Lim, Sher-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597986/
https://www.ncbi.nlm.nih.gov/pubmed/36289500
http://dx.doi.org/10.1186/s12893-022-01773-y
_version_ 1784816221901815808
author Yang, Kai-shun
Chen, Chih-Wei
Yau, Ru-Bin
Liang, Huang-Chien
Ko, Ching-Chung
Kuo, Jinn-Rung
Chio, Chung-Ching
Lim, Sher-Wei
author_facet Yang, Kai-shun
Chen, Chih-Wei
Yau, Ru-Bin
Liang, Huang-Chien
Ko, Ching-Chung
Kuo, Jinn-Rung
Chio, Chung-Ching
Lim, Sher-Wei
author_sort Yang, Kai-shun
collection PubMed
description BACKGROUND: Transforaminal Lumbar Interbody Fusion (TLIF) is commonly associated with higher complications and longer operative time. This study aims to evaluate the effectiveness, safety, and usability of a novel minimally invasive surgery (MIS) bone graft delivery device. METHODS: 73 consecutive patients with lumbar spondylosis, degenerative disc disease, spondylolisthesis, scoliosis or trauma were enrolled in this randomized controlled trial. Group 1 comprised 39 patients treated with the novel MIS bone graft delivery device. Group 2 consisted of 34 patients treated with the conventional system. The primary objective of the study was the assessment of the amount of bone graft delivery using the device. The secondary objectives were the effect of the device on operative time, pain relief, disability improvement, and bone fusion grade. RESULTS: Bone delivery amount was significantly higher in the MIS device group (6.7 ± 2.9 mL) compared to the conventional group (2.3 ± 0.5 mL), p < 0.001. Regarding the operation time, the MIS device group was associated significantly lower duration than the conventional group (p < 0.001). After a 3-month follow-up, 39.5% of the patients in the MIS device group and 3.5% of the patients in the conventional group were observed to achieve grade I fusion (complete fusion). There was a significant difference in fusion success rates (p < 0.01). CONCLUSION: The novel MIS bone graft delivery device was associated with successful bone delivery. Our MIS device provides promising modality with less operative time and higher bone fusion rates than conventional modalities. Trial Registration This trial was retrospectively registered on ClinicalTrials.gov (Registration date: 11/19/2021; Registration number: NCT05190055). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01773-y.
format Online
Article
Text
id pubmed-9597986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95979862022-10-27 A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery Yang, Kai-shun Chen, Chih-Wei Yau, Ru-Bin Liang, Huang-Chien Ko, Ching-Chung Kuo, Jinn-Rung Chio, Chung-Ching Lim, Sher-Wei BMC Surg Research BACKGROUND: Transforaminal Lumbar Interbody Fusion (TLIF) is commonly associated with higher complications and longer operative time. This study aims to evaluate the effectiveness, safety, and usability of a novel minimally invasive surgery (MIS) bone graft delivery device. METHODS: 73 consecutive patients with lumbar spondylosis, degenerative disc disease, spondylolisthesis, scoliosis or trauma were enrolled in this randomized controlled trial. Group 1 comprised 39 patients treated with the novel MIS bone graft delivery device. Group 2 consisted of 34 patients treated with the conventional system. The primary objective of the study was the assessment of the amount of bone graft delivery using the device. The secondary objectives were the effect of the device on operative time, pain relief, disability improvement, and bone fusion grade. RESULTS: Bone delivery amount was significantly higher in the MIS device group (6.7 ± 2.9 mL) compared to the conventional group (2.3 ± 0.5 mL), p < 0.001. Regarding the operation time, the MIS device group was associated significantly lower duration than the conventional group (p < 0.001). After a 3-month follow-up, 39.5% of the patients in the MIS device group and 3.5% of the patients in the conventional group were observed to achieve grade I fusion (complete fusion). There was a significant difference in fusion success rates (p < 0.01). CONCLUSION: The novel MIS bone graft delivery device was associated with successful bone delivery. Our MIS device provides promising modality with less operative time and higher bone fusion rates than conventional modalities. Trial Registration This trial was retrospectively registered on ClinicalTrials.gov (Registration date: 11/19/2021; Registration number: NCT05190055). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01773-y. BioMed Central 2022-10-26 /pmc/articles/PMC9597986/ /pubmed/36289500 http://dx.doi.org/10.1186/s12893-022-01773-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Kai-shun
Chen, Chih-Wei
Yau, Ru-Bin
Liang, Huang-Chien
Ko, Ching-Chung
Kuo, Jinn-Rung
Chio, Chung-Ching
Lim, Sher-Wei
A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title_full A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title_fullStr A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title_full_unstemmed A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title_short A novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
title_sort novel surgical technique in transforaminal lumbar interbody fusion by the bone graft delivery device: evaluation of therapeutic effect in patients with minimally invasive spine surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597986/
https://www.ncbi.nlm.nih.gov/pubmed/36289500
http://dx.doi.org/10.1186/s12893-022-01773-y
work_keys_str_mv AT yangkaishun anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT chenchihwei anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT yaurubin anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT lianghuangchien anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT kochingchung anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT kuojinnrung anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT chiochungching anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT limsherwei anovelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT yangkaishun novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT chenchihwei novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT yaurubin novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT lianghuangchien novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT kochingchung novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT kuojinnrung novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT chiochungching novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery
AT limsherwei novelsurgicaltechniqueintransforaminallumbarinterbodyfusionbythebonegraftdeliverydeviceevaluationoftherapeuticeffectinpatientswithminimallyinvasivespinesurgery